Heterogeneity versus homogeneity of multiple sclerosis

Expert Rev Clin Immunol. 2011 Mar;7(2):165-7. doi: 10.1586/eci.11.3.

Abstract

The 10th International Congress of Neuroimmunology, including the 10th European School of Neuroimmunology Course, was held by the International Society of Neuroimmunology in Sitges (Barcelona, Spain) on 26-30 October 2010. The conference covered a wide spectrum of issues and challenges in both basic science and clinical aspects of neuroimmunology. Data and ideas were shared through a variety of programs, including review talks and poster sessions. One of the topics of the congress was whether multiple sclerosis is a homogenous or heterogenous disease, clinically and pathologically, throughout its course.

Publication types

  • Congress

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Clinical Trials as Topic
  • Disease Progression
  • Humans
  • Immunotherapy*
  • Lymphocyte Depletion
  • Models, Animal
  • Multiple Sclerosis, Chronic Progressive / immunology*
  • Multiple Sclerosis, Chronic Progressive / physiopathology
  • Multiple Sclerosis, Chronic Progressive / therapy
  • Multiple Sclerosis, Relapsing-Remitting / immunology*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology
  • Multiple Sclerosis, Relapsing-Remitting / therapy
  • Neuritis
  • Neuroimmunomodulation
  • Spain
  • T-Lymphocyte Subsets / drug effects*
  • T-Lymphocyte Subsets / immunology

Substances

  • Antibodies, Monoclonal